Alterations in acetylcholine, PGE2 and IL6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide

Toxicology in Vitro

Volumn 27, Issue 6, 2013, Pages 1693-1698

  McDermott, C ^a   Chess Williams, R ^a   Mills, K A ^a   Kang, S H ^a   Farr, S E ^a   Grant, G D ^b   Perkins, A V ^b   Davey, A K ^b   Anoopkumar Dukie, S ^b  

^a BOND UNIVERSITY   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

Acetylcholine; Inflammation; Lipopolysaccharide; PGE2; Pyocyanin; Urothelium

Indexed keywords

ACETYLCHOLINE; INTERLEUKIN 12; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; PYOCYANINE; VIRULENCE FACTOR; IL6 PROTEIN, HUMAN;

ARTICLE; BACTERIAL VIRULENCE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ESCHERICHIA COLI; HUMAN; HUMAN CELL; MEDIATOR RELEASE; NONHUMAN; PSEUDOMONAS AERUGINOSA; UROTHELIUM; UROTHELIUM CELL; CELL LINE; CYTOLOGY; DRUG EFFECT; EPITHELIUM CELL; INFLAMMATION; METABOLISM; DRUG EFFECTS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; PSEUDOMONAS AERUGINOSA;

ACETYLCHOLINE; INFLAMMATION; LIPOPOLYSACCHARIDE; PGE2; PYOCYANIN; UROTHELIUM;

ACETYLCHOLINE; CELL LINE; DINOPROSTONE; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-12; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; PYOCYANINE; UROTHELIUM;

EID: 84878376123     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2013.04.015     Document Type: Article

References (50)

1. Agace W.W., Hedges S.R., Ceska M., Svanborg C. Interleukin-8 and the neutrophil response to mucosal gram-negative infection. J. Clin. Invest. 1993, 92:780-785.
2. Aizawa N., Igawa Y., Nishizawa O., Wyndaele J.J. Effects of CL316,243, a beta 3-adrenoceptor agonist, and intravesical prostaglandin E2 on the primary bladder afferent activity of the rat. Neurourol. Urodyn. 2010, 29:771-776.
3. Akino H., Chapple C.R., McKay N., Cross R.L., Murakami S., Yokoyama O., Chess-Williams R., Sellers D.J. Spontaneous contractions of the pig urinary bladder: the effect of ATP-sensitive potassium channels and the role of the mucosa. BJU Int. 2008, 102:1168-1174.
4. Amna M.A., Chazan B., Raz R., Edelstein H., Colodner R. Risk factors for non-Escherichia coli community-acquired bacteriuria. Infection 2013, 41(2):473-477.
5. Anoopkumar-Dukie S., Carey J.B., Conere T., O'Sullivan E., van Pelt F.N., Allshire A. Resazurin assay of radiation response in cultured cells. Br. J. Radiol. 2005, 78:945-947.
6. Aoki K., Hirayama A., Tanaka N., Yoneda T., Yoshida K., Fujimoto K., Hirao Y. A higher level of prostaglandin E2 in the urinary bladder in young boys and boys with lower urinary tract obstruction. Biomed. Res. 2009, 30:343-347.
7. Burnstock G. Purinergic receptors and pain. Curr. Pharm. Des. 2009, 15:1717-1735.
8. Daly D.M., Chess-Williams R., Chapple C., Grundy D. The inhibitory role of acetylcholine and muscarinic receptors in bladder afferent activity. Eur. Urol. 2010, 58:22-28. (discussion 31-22).
9. Davies J.C. Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence. Paediatr. Respir. Rev. 2002, 3:128-134.
10. Dormehl I., Ras G., Taylor G., Hugo N. Effect of Pseudomonas aeruginosa-derived pyocyanin and 1-hydroxyphenazine on pulmonary mucociliary clearance monitored scintigraphically in the baboon model. Int. J. Rad. Appl. Instrum. B 1991, 18:455-459.
11. Ferguson D.R., Kennedy I., Burton T.J. ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes - a possible sensory mechanism?. J. Physiol. 1997, 505(Pt 2):503-511.
12. Foxman B., Brown P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect. Dis. Clin. North Am. 2003, 17:227-241.
13. Gloyne L.S., Grant G.D., Perkins A.V., Powell K.L., McDermott C.M., Johnson P.V., Anderson G.J., Kiefel M., Anoopkumar-Dukie S. Pyocyanin-induced toxicity in A549 respiratory cells is causally linked to oxidative stress. Toxicol. In Vitro 2011, 25:1353-1358.
14. Gupta R.K., Chhibber S., Harjai K. Quorum sensing signal molecules cause renal tissue inflammation through local cytokine responses in experimental UTI caused by Pseudomonas aeruginosa. Immunobiology 2013, 218:181-185.
15. Hammond S.M. Inhibitors of lipopolysaccharide biosynthesis impair the virulence potential of Escherichia coli. FEMS Microbiol. Lett. 1992, 79:293-297.
16. Hanna-Mitchell A.T., Beckel J.M., Barbadora S., Kanai A.J., de Groat W.C., Birder L.A. Non-neuronal acetylcholine and urinary bladder urothelium. Life Sci. 2007, 80:2298-2302.
17. Hannan T.J., Mysorekar I.U., Hung C.S., Isaacson-Schmid M.L., Hultgren S.J. Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog. 2010, 6:e1001042.
18. Hayashi Y., Takimoto K., Chancellor M.B., Erickson K.A., Erickson V.L., Kirimoto T., Nakano K., de Groat W.C., Yoshimura N. Bladder hyperactivity and increased excitability of bladder afferent neurons associated with reduced expression of Kv1.4 alpha-subunit in rats with cystitis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296:R1661-1670.
19. Heinrich M., Oberbach A., Schlichting N., Stolzenburg J.U., Neuhaus J. Cytokine effects on gap junction communication and connexin expression in human bladder smooth muscle cells and suburothelial myofibroblasts. PLoS One 2011, 6:e20792.
20. Ishizuka O., Mattiasson A., Andersson K.E. Prostaglandin E2-induced bladder hyperactivity in normal, conscious rats: involvement of tachykinins?. J. Urol. 1995, 153:2034-2038.
21. Jaggar S.I., Scott H.C., James I.F., Rice A.S. The capsaicin analogue SDZ249-665 attenuates the hyper-reflexia and referred hyperalgesia associated with inflammation of the rat urinary bladder. Pain 2001, 89:229-235.
22. Jantausch B.A., O'Donnell R., Wiedermann B.L. Urinary interleukin-6 and interleukin-8 in children with urinary tract infection. Pediatr. Nephrol. 2000, 15:236-240.
23. Kang S.H., Chess-Williams R., Anoopkumar-Dukie S., McDermott C. Induction of inflammatory cytokines and alteration of urothelial ATP, acetylcholine and prostaglandin E(2) release by doxorubicin. Eur. J. Pharmacol. 2013, 700:102-109.
24. Kim J.C., Park E.Y., Hong S.H., Seo S.I., Park Y.H., Hwang T.K. Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom. Int. J. Urol. 2005, 12:875-880.
25. Kim J.C., Park E.Y., Seo S.I., Park Y.H., Hwang T.K. Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J. Urol. 2006, 175:1773-1776.
26. Kitao T., Tada T., Tanaka M., Narahara K., Shimojima M., Shimada K., Miyoshi-Akiyama T., Kirikae T. Emergence of a novel multidrug-resistant Pseudomonas aeruginosa strain producing IMP-type metallo-beta-lactamases and AAC(6')-Iae in Japan. Int. J. Antimicrob. Agents 2012, 39:518-521.
27. Kumar V., Chapple C.R., Surprenant A.M., Chess-Williams R. Enhanced adenosine triphosphate release from the urothelium of patients with painful bladder syndrome: a possible pathophysiological explanation. J. Urol. 2007, 178:1533-1536.
28. Lau G.W., Ran H., Kong F., Hassett D.J., Mavrodi D. Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice. Infect. Immun. 2004, 72:4275-4278.
29. Liao K.S., Lehman S.M., Tweardy D.J., Donlan R.M., Trautner B.W. Bacteriophages are synergistic with bacterial interference for the prevention of Pseudomonas aeruginosa biofilm formation on urinary catheters. J. Appl. Microbiol. 2012, 113:1530-1539.
30. Maggi C.A., Giuliani S., Patacchini R., Conte B., Furio M., Santicioli P., Meli P., Gragnani L., Meli A. The effect of SC-19220, a prostaglandin antagonist, on the micturition reflex in rats. Eur. J. Pharmacol. 1988, 152:273-279.
31. Mansfield K., Cheng Y., Moore K. Treatment of urothelial cells with lipopolysaccharide from enteropathogenic E. coli reduces stretch induced ATP release. J. Urol. 2012, 187:e368-369.
32. McDermott C., Chess-Williams R., Grant G.D., Perkins A.V., McFarland A.J., Davey A.K., Anoopkumar-Dukie S. Effects of Pseudomonas aeruginosa virulence factor pyocyanin on human urothelial cell function and viability. J. Urol. 2012, 187:1087-1093.
33. Mittal R., Aggarwal S., Sharma S., Chhibber S., Harjai K. Urinary tract infections caused by Pseudomonas aeruginosa: a minireview. J. Infect. Public Health 2009, 2:101-111.
34. Moro C., Uchiyama J., Chess-Williams R. Urothelial/lamina propria spontaneous activity and the role of M3 muscarinic receptors in mediating rate responses to stretch and carbachol. Urology 2011, 78(1442):e9-15.
35. Muller M. Pyocyanin induces oxidative stress in human endothelial cells and modulates the glutathione redox cycle. Free Radic. Biol. Med. 2002, 33:1527-1533.
36. Nile C.J., de Vente J., Gillespie J.I. Stretch independent regulation of prostaglandin E(2) production within the isolated guinea-pig lamina propria. BJU Int. 2010, 105:540-548.
37. Nomiya M., Sagawa K., Yazaki J., Takahashi N., Kushida N., Haga N., Aikawa K., Matsui T., Oka M., Fukui T., Andersson K.E., Yamaguchi O. Increased bladder activity is associated with elevated oxidative stress markers and proinflammatory cytokines in a rat model of atherosclerosis-induced chronic bladder ischemia. Neurourol. Urodyn. 2012, 31:185-189.
38. Olsson L.E., Wheeler M.A., Sessa W.C., Weiss R.M. Bladder instillation and intraperitoneal injection of Escherichia coli lipopolysaccharide up-regulate cytokines and iNOS in rat urinary bladder. J. Pharmacol. Exp. Ther. 1998, 284:1203-1208.
39. Parsons C.L. Interstitial cystitis and lower urinary tract symptoms in males and females-the combined role of potassium and epithelial dysfunction. Rev. Urol. 2002, 4(Suppl. 1):S49-55.
40. Pier G.B. Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity. Int. J. Med. Microbiol. 2007, 297:277-295.
41. Rada B., Gardina P., Myers T.G., Leto T.L. Reactive oxygen species mediate inflammatory cytokine release and EGFR-dependent mucin secretion in airway epithelial cells exposed to Pseudomonas pyocyanin. Mucosal Immunol. 2011, 4:158-171.
42. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am. J. Med. 2002, 113(Suppl. 1A):14S-19S.
43. Rugo H.S., O'Hanley P., Bishop A.G., Pearce M.K., Abrams J.S., Howard M., O'Garra A. Local cytokine production in a murine model of Escherichia coli pyelonephritis. J. Clin. Invest. 1992, 89:1032-1039.
44. Rumbaugh K.P., Griswold J.A., Hamood A.N. Pseudomonas aeruginosa strains obtained from patients with tracheal, urinary tract and wound infection: variations in virulence factors and virulence genes. J. Hosp. Infect. 1999, 43:211-218.
45. Stevens L.A., Chapple C.R., Chess-Williams R. Human idiopathic and neurogenic overactive bladders and the role of M2 muscarinic receptors in contraction. Eur. Urol. 2007, 52:531-538.
46. Stewart-Tull D.E., Armstrong A.V. The effect of 1-hydroxyphenazine and pyocyanin from Pseudomonas aeruginosa on mammalian cell respiration. J. Med. Microbiol. 1972, 5:67-73.
47. Tanaka I., Nagase K., Tanase K., Aoki Y., Akino H., Yokoyama O. Modulation of stretch evoked adenosine triphosphate release from bladder epithelium by prostaglandin E(2). J. Urol. 2011, 185:341-346.
48. Walsh C.A., Cheng Y., Mansfield K.J., Parkin K., Mukerjee C., Moore K.H. Decreased intravesical ATP in patients with refractory detrusor overactivity and bacteriuria. J. Urol. 2013, 189(4):1383-1387.
49. Weng T.I., Chen W.J., Liu S.H. Bladder instillation of Escherichia coli lipopolysaccharide alters the muscle contractions in rat urinary bladder via a protein kinase C-related pathway. Toxicol. Appl. Pharmacol. 2005, 208:163-169.
50. Wilson R., Sykes D.A., Watson D., Rutman A., Taylor G.W., Cole P.J. Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect. Immun. 1988, 56:2515-2517.